Share Price and Basic Stock Data
Last Updated: November 18, 2025, 7:29 pm
| PEG Ratio | -1.71 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Dolat Algotech Ltd operates in the Finance & Investments sector, with a current market capitalization of ₹1,411 Cr and a share price of ₹80.3. The company has demonstrated fluctuating revenue trends, with reported sales of ₹190 Cr for the fiscal year ending March 2023, which rose significantly to ₹305 Cr for March 2024 and is projected to reach ₹424 Cr for March 2025. Quarterly sales figures highlight a notable recovery, with the latest quarter (Sep 2023) recording sales of ₹71 Cr, increasing to ₹81 Cr in December 2023, and further projected growth to ₹117 Cr in March 2024. Despite past fluctuations, particularly a low of ₹8 Cr in March 2023, the overall trajectory suggests a robust recovery, supported by an operational model that maintains a high operating profit margin (OPM) of 71%. The company’s resilience in revenue generation positions it favorably within the competitive landscape of finance and investments.
Profitability and Efficiency Metrics
Dolat Algotech Ltd reported a net profit of ₹183 Cr, translating to a price-to-earnings (P/E) ratio of 7.73, indicative of attractive valuation compared to the broader market. The company boasts a return on equity (ROE) of 24% and a return on capital employed (ROCE) of 32%, both of which are considerably higher than typical sector averages. The operating profit margin (OPM) stood at an impressive 71%, reflecting strong operational efficiency. Notably, the interest coverage ratio (ICR) was reported at 7.82x, showcasing the company’s ability to cover interest obligations comfortably. However, the company’s profitability was impacted by a significant operating loss of ₹6 Cr in March 2023, which highlights potential vulnerabilities in its operational execution during challenging periods. The recent recovery in net profits, particularly the rise to ₹68 Cr in March 2024, emphasizes the ongoing improvement in profitability, reinforcing investor confidence in its operational strategies.
Balance Sheet Strength and Financial Ratios
Dolat Algotech Ltd’s balance sheet reflects a solid financial position, with total assets reported at ₹1,132 Cr and total liabilities at ₹1,132 Cr, indicating a balanced approach to leveraging. The company’s reserves have grown to ₹986 Cr, providing a buffer for future growth and operational flexibility. Borrowings stood at ₹66 Cr, showcasing a low debt-to-equity ratio of 0.06, which is significantly lower than typical sector norms, suggesting prudent financial management. The current ratio of 4.99x further highlights liquidity, ensuring that the company can meet its short-term obligations without strain. The book value per share has increased to ₹57, representing strong shareholder equity. However, the absence of significant fixed assets may limit growth potential in capital-intensive ventures. Overall, the balance sheet’s strength is a key asset for Dolat Algotech, allowing it to navigate market fluctuations effectively.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Dolat Algotech Ltd indicates a strong promoter holding of 74.49%, which reflects significant insider confidence in the company’s future. Foreign institutional investors (FIIs) hold a minimal 0.09%, while domestic institutional investors (DIIs) account for only 0.01%. This limited institutional interest may suggest a lack of broader market confidence or awareness. The public shareholding stands at 25.42%, indicating a relatively dispersed ownership structure with approximately 63,420 shareholders. Over recent quarters, the number of shareholders has fluctuated, with a notable increase to 64,015 by March 2025, which may reflect growing interest from retail investors. However, the low institutional participation could be a concern, as it often signals caution among larger investors regarding the company’s growth prospects. The stability of promoter holdings, however, is a positive indicator, suggesting that those closest to the company remain committed to its long-term success.
Outlook, Risks, and Final Insight
The outlook for Dolat Algotech Ltd appears cautiously optimistic, bolstered by recent improvements in revenue and profitability metrics. The company’s ability to maintain a high operating profit margin and low debt levels positions it well against potential market challenges. However, risks remain, including the volatility in quarterly sales and the significant operational loss reported in early 2023, which could impact investor sentiment. The low institutional interest may also pose challenges in attracting larger investments, potentially limiting future growth. If the company can sustain its sales momentum and enhance operational efficiency, it could capitalize on its robust financial position to explore new growth avenues. Conversely, failure to maintain profitability during market fluctuations could hinder its recovery trajectory. Overall, Dolat Algotech Ltd’s financial health and strategic positioning provide a solid foundation for future growth, contingent upon effective operational execution and market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Dolat Algotech Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Monarch Networth Capital Ltd | 2,542 Cr. | 321 | 484/280 | 16.4 | 111 | 0.31 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 35.9 Cr. | 0.51 | 2.42/0.46 | 4.97 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.14 Cr. | 8.37 | 12.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 25.7 Cr. | 50.0 | 72.0/47.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Naperol Investments Ltd | 513 Cr. | 892 | 1,510/0.00 | 53.3 | 2,055 | 1.01 % | 1.06 % | 0.95 % | 10.0 |
| Industry Average | 6,984.97 Cr | 1,433.51 | 76.62 | 3,872.09 | 0.34% | 21.83% | 14.30% | 7.26 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49 | 54 | 43 | 8 | 36 | 71 | 81 | 117 | 123 | 120 | 94 | 87 | 83 |
| Expenses | 13 | 16 | 15 | 15 | 14 | 20 | 23 | 23 | 24 | 25 | 36 | 25 | 24 |
| Operating Profit | 36 | 38 | 28 | -6 | 22 | 51 | 58 | 94 | 99 | 95 | 58 | 62 | 59 |
| OPM % | 73% | 70% | 66% | -77% | 62% | 72% | 72% | 80% | 80% | 79% | 61% | 71% | 71% |
| Other Income | 19 | 19 | 17 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 7 | 5 | 7 | 6 | 6 | 6 | 7 | 8 | 9 | 11 | 12 | 12 | 10 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Profit before tax | 47 | 52 | 37 | 6 | 15 | 44 | 51 | 85 | 89 | 84 | 45 | 49 | 48 |
| Tax % | 18% | 20% | 21% | -9% | 17% | 21% | 19% | 20% | 20% | 20% | 16% | 19% | 19% |
| Net Profit | 38 | 41 | 30 | 7 | 13 | 35 | 41 | 68 | 72 | 67 | 37 | 40 | 39 |
| EPS in Rs | 2.17 | 2.35 | 1.68 | 0.39 | 0.73 | 1.99 | 2.35 | 3.87 | 4.07 | 3.79 | 2.12 | 2.25 | 2.21 |
Last Updated: August 19, 2025, 7:55 pm
Below is a detailed analysis of the quarterly data for Dolat Algotech Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 87.00 Cr. (Mar 2025) to 83.00 Cr., marking a decrease of 4.00 Cr..
- For Expenses, as of Jun 2025, the value is 24.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 1.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 59.00 Cr.. The value appears to be declining and may need further review. It has decreased from 62.00 Cr. (Mar 2025) to 59.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is 71.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 71.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Jun 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00%.
- For Net Profit, as of Jun 2025, the value is 39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Mar 2025) to 39.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.21. The value appears to be declining and may need further review. It has decreased from 2.25 (Mar 2025) to 2.21, marking a decrease of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 182 | 34 | 89 | 83 | 139 | 116 | 93 | 219 | 262 | 190 | 305 | 424 | 298 |
| Expenses | 226 | 29 | 85 | 81 | 95 | 33 | 21 | 34 | 47 | 55 | 80 | 110 | 104 |
| Operating Profit | -43 | 5 | 4 | 2 | 43 | 83 | 72 | 185 | 215 | 135 | 226 | 314 | 194 |
| OPM % | -24% | 15% | 5% | 2% | 31% | 71% | 77% | 85% | 82% | 71% | 74% | 74% | 65% |
| Other Income | 0 | 0 | 0 | 0 | 4 | 0 | 29 | 29 | 27 | 37 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 5 | 16 | 28 | 27 | 30 | 28 | 44 | 46 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 |
| Profit before tax | -43 | 5 | 4 | 2 | 47 | 78 | 85 | 186 | 215 | 142 | 196 | 267 | 145 |
| Tax % | -33% | 31% | 30% | 24% | 34% | 35% | 17% | 21% | 22% | 18% | 20% | 19% | |
| Net Profit | -29 | 3 | 3 | 1 | 31 | 51 | 71 | 147 | 167 | 116 | 157 | 215 | 120 |
| EPS in Rs | -1.65 | 0.19 | 0.17 | 0.08 | 1.77 | 2.87 | 4.04 | 8.34 | 9.51 | 6.59 | 8.94 | 12.24 | 6.84 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 3% | 2% | 2% | 2% | 4% | 3% | 2% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 110.34% | 0.00% | -66.67% | 3000.00% | 64.52% | 39.22% | 107.04% | 13.61% | -30.54% | 35.34% | 36.94% |
| Change in YoY Net Profit Growth (%) | 0.00% | -110.34% | -66.67% | 3066.67% | -2935.48% | -25.30% | 67.83% | -93.44% | -44.14% | 65.88% | 1.60% |
Dolat Algotech Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 35% |
| 3 Years: | 17% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 52% |
| 5 Years: | 25% |
| 3 Years: | 9% |
| TTM: | -16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 50% |
| 5 Years: | 9% |
| 3 Years: | 4% |
| 1 Year: | -53% |
| Return on Equity | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 27% |
| 3 Years: | 22% |
| Last Year: | 24% |
Last Updated: September 5, 2025, 3:16 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 3 | 113 | 53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 43 | 552 | 72 | 203 | 0 | |||||||
| Days Payable | 0 | 4 | 0 | 1 | ||||||||
| Cash Conversion Cycle | 46 | 661 | 125 | 202 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | 55 | 545 | 171 | 223 | 129 | 198 | -90 | 140 | 449 | 627 | 431 | 489 |
| ROCE % | -55% | 8% | 6% | 3% | 50% | 65% | 53% | 60% | 41% | 23% | 27% | 32% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 12.24 | 8.94 | 6.59 | 9.51 | 8.35 |
| Diluted EPS (Rs.) | 12.24 | 8.94 | 6.59 | 9.51 | 8.35 |
| Cash EPS (Rs.) | 12.41 | 9.03 | 6.65 | 9.55 | 8.37 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 57.00 | 45.06 | 36.36 | 30.00 | 20.68 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 57.00 | 45.06 | 36.36 | 30.00 | 20.68 |
| Revenue From Operations / Share (Rs.) | 30.11 | 18.83 | 13.71 | 16.64 | 15.06 |
| PBDIT / Share (Rs.) | 19.76 | 14.16 | 10.79 | 14.55 | 12.90 |
| PBIT / Share (Rs.) | 19.63 | 14.09 | 10.75 | 14.53 | 12.88 |
| PBT / Share (Rs.) | 17.10 | 12.47 | 9.24 | 13.09 | 11.44 |
| Net Profit / Share (Rs.) | 12.28 | 8.96 | 6.61 | 9.53 | 8.35 |
| NP After MI And SOA / Share (Rs.) | 12.24 | 8.94 | 6.59 | 9.51 | 8.34 |
| PBDIT Margin (%) | 65.62 | 75.16 | 78.66 | 87.44 | 85.65 |
| PBIT Margin (%) | 65.18 | 74.81 | 78.36 | 87.32 | 85.54 |
| PBT Margin (%) | 56.79 | 66.23 | 67.35 | 78.70 | 75.97 |
| Net Profit Margin (%) | 40.77 | 47.58 | 48.21 | 57.27 | 55.46 |
| NP After MI And SOA Margin (%) | 40.65 | 47.46 | 48.06 | 57.17 | 55.35 |
| Return on Networth / Equity (%) | 21.47 | 19.86 | 18.14 | 31.73 | 40.33 |
| Return on Capital Employeed (%) | 34.33 | 31.19 | 29.48 | 48.37 | 61.81 |
| Return On Assets (%) | 18.90 | 16.81 | 14.41 | 21.88 | 29.34 |
| Total Debt / Equity (X) | 0.06 | 0.10 | 0.21 | 0.33 | 0.31 |
| Asset Turnover Ratio (%) | 0.51 | 0.38 | 0.30 | 0.36 | 0.52 |
| Current Ratio (X) | 4.99 | 3.19 | 2.59 | 1.81 | 0.97 |
| Quick Ratio (X) | 4.99 | 3.19 | 2.59 | 1.81 | 0.97 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 2.79 | 3.79 | 2.10 | 1.79 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 2.77 | 3.77 | 2.09 | 1.79 |
| Earning Retention Ratio (%) | 0.00 | 97.21 | 96.21 | 97.90 | 98.21 |
| Cash Earning Retention Ratio (%) | 0.00 | 97.23 | 96.23 | 97.91 | 98.21 |
| Interest Coverage Ratio (X) | 7.82 | 8.76 | 7.14 | 10.14 | 8.95 |
| Interest Coverage Ratio (Post Tax) (X) | 5.86 | 6.55 | 5.38 | 7.64 | 6.80 |
| Enterprise Value (Cr.) | 1534.77 | 1280.69 | 883.77 | 1661.22 | 1269.88 |
| EV / Net Operating Revenue (X) | 2.90 | 3.86 | 3.66 | 5.67 | 4.79 |
| EV / EBITDA (X) | 4.41 | 5.14 | 4.66 | 6.49 | 5.59 |
| MarketCap / Net Operating Revenue (X) | 2.79 | 3.63 | 3.08 | 5.09 | 4.65 |
| Retention Ratios (%) | 0.00 | 97.20 | 96.20 | 97.89 | 98.20 |
| Price / BV (X) | 1.47 | 1.52 | 1.16 | 2.82 | 3.39 |
| Price / Net Operating Revenue (X) | 2.79 | 3.63 | 3.08 | 5.09 | 4.65 |
| EarningsYield | 0.14 | 0.13 | 0.15 | 0.11 | 0.11 |
After reviewing the key financial ratios for Dolat Algotech Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.24. This value is within the healthy range. It has increased from 8.94 (Mar 24) to 12.24, marking an increase of 3.30.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.24. This value is within the healthy range. It has increased from 8.94 (Mar 24) to 12.24, marking an increase of 3.30.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.41. This value is within the healthy range. It has increased from 9.03 (Mar 24) to 12.41, marking an increase of 3.38.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.00. It has increased from 45.06 (Mar 24) to 57.00, marking an increase of 11.94.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.00. It has increased from 45.06 (Mar 24) to 57.00, marking an increase of 11.94.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 30.11. It has increased from 18.83 (Mar 24) to 30.11, marking an increase of 11.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 19.76. This value is within the healthy range. It has increased from 14.16 (Mar 24) to 19.76, marking an increase of 5.60.
- For PBIT / Share (Rs.), as of Mar 25, the value is 19.63. This value is within the healthy range. It has increased from 14.09 (Mar 24) to 19.63, marking an increase of 5.54.
- For PBT / Share (Rs.), as of Mar 25, the value is 17.10. This value is within the healthy range. It has increased from 12.47 (Mar 24) to 17.10, marking an increase of 4.63.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.28. This value is within the healthy range. It has increased from 8.96 (Mar 24) to 12.28, marking an increase of 3.32.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.24. This value is within the healthy range. It has increased from 8.94 (Mar 24) to 12.24, marking an increase of 3.30.
- For PBDIT Margin (%), as of Mar 25, the value is 65.62. This value is within the healthy range. It has decreased from 75.16 (Mar 24) to 65.62, marking a decrease of 9.54.
- For PBIT Margin (%), as of Mar 25, the value is 65.18. This value exceeds the healthy maximum of 20. It has decreased from 74.81 (Mar 24) to 65.18, marking a decrease of 9.63.
- For PBT Margin (%), as of Mar 25, the value is 56.79. This value is within the healthy range. It has decreased from 66.23 (Mar 24) to 56.79, marking a decrease of 9.44.
- For Net Profit Margin (%), as of Mar 25, the value is 40.77. This value exceeds the healthy maximum of 10. It has decreased from 47.58 (Mar 24) to 40.77, marking a decrease of 6.81.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 40.65. This value exceeds the healthy maximum of 20. It has decreased from 47.46 (Mar 24) to 40.65, marking a decrease of 6.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.47. This value is within the healthy range. It has increased from 19.86 (Mar 24) to 21.47, marking an increase of 1.61.
- For Return on Capital Employeed (%), as of Mar 25, the value is 34.33. This value is within the healthy range. It has increased from 31.19 (Mar 24) to 34.33, marking an increase of 3.14.
- For Return On Assets (%), as of Mar 25, the value is 18.90. This value is within the healthy range. It has increased from 16.81 (Mar 24) to 18.90, marking an increase of 2.09.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. It has decreased from 0.10 (Mar 24) to 0.06, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.51. It has increased from 0.38 (Mar 24) to 0.51, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 25, the value is 4.99. This value exceeds the healthy maximum of 3. It has increased from 3.19 (Mar 24) to 4.99, marking an increase of 1.80.
- For Quick Ratio (X), as of Mar 25, the value is 4.99. This value exceeds the healthy maximum of 2. It has increased from 3.19 (Mar 24) to 4.99, marking an increase of 1.80.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.79 (Mar 24) to 0.00, marking a decrease of 2.79.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.77 (Mar 24) to 0.00, marking a decrease of 2.77.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.21 (Mar 24) to 0.00, marking a decrease of 97.21.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.23 (Mar 24) to 0.00, marking a decrease of 97.23.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.82. This value is within the healthy range. It has decreased from 8.76 (Mar 24) to 7.82, marking a decrease of 0.94.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.86. This value is within the healthy range. It has decreased from 6.55 (Mar 24) to 5.86, marking a decrease of 0.69.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,534.77. It has increased from 1,280.69 (Mar 24) to 1,534.77, marking an increase of 254.08.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.90. This value is within the healthy range. It has decreased from 3.86 (Mar 24) to 2.90, marking a decrease of 0.96.
- For EV / EBITDA (X), as of Mar 25, the value is 4.41. This value is below the healthy minimum of 5. It has decreased from 5.14 (Mar 24) to 4.41, marking a decrease of 0.73.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.79. This value is within the healthy range. It has decreased from 3.63 (Mar 24) to 2.79, marking a decrease of 0.84.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 97.20 (Mar 24) to 0.00, marking a decrease of 97.20.
- For Price / BV (X), as of Mar 25, the value is 1.47. This value is within the healthy range. It has decreased from 1.52 (Mar 24) to 1.47, marking a decrease of 0.05.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.79. This value is within the healthy range. It has decreased from 3.63 (Mar 24) to 2.79, marking a decrease of 0.84.
- For EarningsYield, as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has increased from 0.13 (Mar 24) to 0.14, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dolat Algotech Ltd:
- Net Profit Margin: 40.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 34.33% (Industry Average ROCE: 21.83%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.47% (Industry Average ROE: 14.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.86
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.99
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.9 (Industry average Stock P/E: 76.62)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 40.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 1405-1406, Dalal Street Commercial Co-op Soc Ltd, Block 53 (Bldg No.53E) Zone-5, Road-5E, Gift city, Gandhinagar Gujarat 382050 | investor@dolatalgotech.in http://www.dolatalgotech.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Harendra D Shah | Chairman |
| Mr. Pankaj D Shah | Managing Director |
| Mr. Shailesh D Shah | Director |
| Ms. Monika A Singhania | Independent Director |
| Mr. Shailesh K Nayak | Independent Director |
| Mr. Thomas Ritaldo Fernandes | Independent Director |